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Abstract. 
 
Wnt signaling plays a critical role in develop-
ment and oncogenesis. Although signiﬁcant progress
has been made in understanding the downstream sig-
naling cascade of Wnt signaling, little is known regard-
ing Wnt signaling modiﬁcation of the cell death machin-
ery. Given that numerous oncogenes transform cells by
providing cell survival function, we hypothesized that
Wnt signaling may inhibit apoptosis. Here, we report
that cells expressing Wnt-1 were resistant to cancer
therapy–mediated apoptosis. Wnt-1 signaling inhibited
the cytochrome c release and the subsequent caspase-9
activation induced by chemotherapeutic drugs, includ-
ing both vincristine and vinblastine. Furthermore, we
found that Wnt-1–mediated cell survival was dependent
 
on the activation of 
 
b
 
-catenin/T cell factor (Tcf) tran-
scription. Inhibition of 
 
b
 
-catenin/Tcf transcription by
expression of the dominant-negative mutant of Tcf-4
blocked Wnt-1–mediated cell survival and rendered
cells sensitive to apoptotic stimuli. These results pro-
vide the ﬁrst demonstration that Wnt-1 inhibits cancer
therapy–mediated apoptosis and suggests that Wnt-1
may exhibit its oncogenic potential through a mecha-
nism of anti-apoptosis.
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Introduction
 
The Wnt-1 gene encodes a secreted cell-signaling glyco-
protein that plays important roles in embryogenesis and
oncogenesis (Nusse and Varmus, 1992; Cadigan and
Nusse, 1997; Miller et al., 1999; Peifer and Polakis, 2000;
Polakis, 2000). Wnt-1 was originally identified as a pro-
tooncogene activated in mammary carcinoma induced
by mouse mammary tumor virus (Nusse and Varmus,
1992). Previous studies have demonstrated that Wnt-1 is
able to transform several mammary epithelial cell lines,
and that transgenic mice expressing Wnt-1 in the mam-
mary gland develop mammary epithelial hyperplasias
and adenocarcinomas (Wong et al., 1994; Bradley and
 
Brown, 1995; Shimizu et al., 1997). The Wnt signal-
ing pathway has been intensely studied in a variety of
 
organisms. The activation of 
 
b
 
-catenin/T cell factor
 
(Tcf)
 
1
 
–mediated transcription by Wnt signal transduction
has been found to play a key role in its biological functions
(Molenaar et al., 1996; Gat et al., 1998; Orford et al., 1999).
 
In the absence of Wnt signaling, 
 
b
 
-catenin is associated
with a cytoplasmic complex containing the adenomatous
polyposis coli protein (APC), the glycogen synthase kinase-
3
 
b
 
 (GSK-3
 
b
 
), and axin (Su et al., 1993; Yost et al., 1996;
Hayashi et al., 1997; Sakanaka et al., 1998; Sakanaka and
William, 1999). In this complex, GSK-3
 
b
 
 constitutively
phosphorylates 
 
b
 
-catenin at both serine and threonine resi-
 
dues of the NH
 
2
 
-terminal region (known as GSK-3
 
b
 
 con-
sensus sites), which are well conserved within the catenin
family of proteins (Yost et al., 1996; Miller et al., 1999). The
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phosphorylated 
 
b
 
-catenin is targeted by 
 
b
 
-transducing re-
peat–containing protein, a component of the SCF (Skp1-
Cullin-F-box) ubiquitin ligase complex, resulting in the
ubiquitination and the subsequent degradation of 
 
b
 
-cate-
nin by the proteasome (Hart et al., 1999; Kitagawa et al.,
1999; Liu et al., 1999; Maniatis, 1999; Winston et al., 1999).
In the presence of Wnt signaling, a frizzled receptor acti-
vates the intracellular protein, dishevelled, to inhibit APC–
GSK-3
 
b
 
–axin activity, leading to the accumulation of free
cytosolic 
 
b
 
-catenin (Barth et al., 1997; Rubinfeld et al.,
1997; Polakis, 2000). Subsequently, 
 
b
 
-catenin can translo-
cate to the nucleus and form a complex with members of
the lymphocyte enhancer factor (Lef)/Tcf family of tran-
scription factors to activate the expression of target genes.
The Tcf family members alone have no transcriptional acti-
vation functions. 
 
b
 
-Catenin provides transactivation do-
mains and can stimulate transcription activation by binding
to Tcf proteins (Behrens et al., 1996; Hsu et al., 1998; Roose
et al., 1999). Many important genes, including c-myc, cyclin
D1, and metalloproteinase, which are involved in oncogen-
esis, have been identified to be regulated by the activation
of 
 
b
 
-catenin/Tcf–mediated transcription (He et al., 1998;
Crawford et al., 1999b; Kolligs et al., 1999; Shtutman et al.,
1999; Tetsu and McCormick, 1999). Although mutations in
the Wnt gene have not been found in human cancers, muta-
tions in the downstream components of Wnt signaling,
most of which lead to the constitutive activation of 
 
b
 
-cate-
nin/Tcf–mediated transcription, have been found to be as-
sociated with a variety of human cancers (Kinzler and Vo-
gelstein, 1996; Miller et al., 1999). For example, germline
APC mutations can cause hundreds of benign colorectal tu-
mors, some of which develop into cancer. Somatic muta-
tions of the APC gene are associated with 
 
.
 
80% of spo-
radic colorectal adenomas and carcinomas (Kinzler and
Vogelstein, 1996). Mutations in the putative GSK-3
 
b
 
 phos-
phorylation sites of 
 
b
 
-catenin have been found in many hu-
man cancers, such as colorectal cancer, hepatocellular car-
cinoma, and melanoma (Morin et al., 1997; Rubinfeld et al.,
1997; Caca et al., 1999). Most recently, axin mutations have
been identified from hepatocellular carcinoma (Satoh et
al., 2000).
Apoptosis is characterized by condensation of the nu-
cleus, specific protein degradation, and DNA fragmenta-
tion (Chao and Korsmeyer, 1998; Earnshaw et al., 1999;
Vaux, 1999). The caspase family of cysteine proteases has
been identified as critical components in executing the apop-
totic program (Nicholson and Thornberry, 1997; Salvesen
and Dixit, 1997; Cryns and Yuan, 1998; Thornberry and La-
zebnik, 1998; Vaux, 1999). Studies have demonstrated that
mitochondrial damage plays an important function in initi-
ating the cascade of caspase activation in response to stress
stimuli, such as chemotherapeutic drugs (Chao and Kors-
meyer, 1998; Green and Reed, 1998). Disruption of the
outer mitochondrial membrane by apoptotic stimuli results
in the release of cytochrome c into the cytosol (Liu et al.,
1996). Cytochrome c, along with ATP and apoptotic pro-
tease–activating factor-1 (Apaf-1), recruits and processes
procaspase-9 (Li et al., 1996; Zou et al., 1997). The active
caspase-9 subsequently activates effector caspases, such as
caspase-3, that in turn cleave key proteins to induce apop-
tosis (Liu et al., 1996; Zou et al., 1997). Although it is not
known whether Wnt signaling modulates the cell death ma-
chinery, interestingly, overexpression of several down-
stream mediators of Wnt signaling has been found to regu-
 
late apoptosis (Morin et al., 1996; He et al., 1999; Orford et
al., 1999; Strovel and Sussman, 1999). Using an inducible
expression system, Morin et al. found that overexpression
of APC in human colorectal cancer cells induced apoptosis.
Orford et al. reported that ectopic expression of 
 
b
 
-catenin
inhibited apoptosis associated with a loss of attachment to
extracellular matrix (anoikis) by unknown mechanisms.
Paradoxically, overexpression of dishevelled, an active
component of Wnt-1 signaling for stabilization of 
 
b
 
-cate-
nin, has been found to induce apoptosis (Strovel and Suss-
man, 1999). In spite of these findings, the molecular mecha-
nisms by which these mediators exert their effect on cell
survival are not understood.
Given that abnormal activation of Wnt-1 signaling is as-
sociated with tumor formation and development, here, we
directly examined whether Wnt-1 signaling provides cell
survival signals that are capable of overcoming chemother-
apeutic agent–induced apoptosis. We found that Wnt-1 sig-
naling inhibited chemotherapy-induced apoptosis at the
level of the mitochondria, by preventing cytochrome c re-
lease and subsequent caspase-9 activation. Furthermore,
we found that Wnt-1–mediated 
 
b
 
-catenin/Tcf transcription
was responsible for providing protection against apoptosis,
since the inhibition of 
 
b
 
-catenin/Tcf transcription re-
sensitized cells to chemotherapy-induced cell death. This
work provides the first proof that activation of the Wnt-1/
 
b
 
-catenin/Tcf signaling would not only provide a cell growth
advantage to cancer cells, but would also significantly
affect the clinical outcome by inhibiting chemotherapy-
induced apoptosis.
 
Materials and Methods
 
Cell Culture and Stable Transfection
 
Rat-1 cells stably expressing Wnt-1 (Rat-1/Wnt-1) and control Rat-1 cells
stably expressing 
 
b
 
-galactosidase (Rat-1/
 
b
 
-gal) were maintained in DME,
supplemented with 10% heat-inactivated fetal bovine serum, penicillin
(100 
 
m
 
g/ml), and streptomycin (100 
 
m
 
g/ml), at 37
 
8
 
C under 5% CO
 
2
 
 and at
95% humidity (Young et al., 1998). For stable transfection, Rat-1/Wnt-1
cells were cotransfected with pcDNA3-flag-DN-Tcf-4, encoding the domi-
nant-negative mutant (DN) of Tcf-4, or control empty vector and pBabe
vector, containing a puromycin selectable marker, with Superfect
(QIAGEN), according to the manufacturer’s protocol (QIAGEN). 2 d af-
ter transfection, cells were selected for resistance to puromycin at a con-
centration of 1.5 
 
m
 
g/ml for 2 wk. The resistant clones were screened for
DN-Tcf-4 expression with a monoclonal antibody against the flag epitope
after 2 wk of selection. The positive clones were pooled.
 
Trypan Blue Exclusion, Cell Death ELISA, Annexin V 
Staining, and LacZ Survival Assay
 
100,000 cells were plated onto six-well plates the day before stimulation.
Cells were treated with vincristine (VCR, 0.5 
 
m
 
g/ml), vinblastine (VBL,
0.5 
 
m
 
g/ml), or tumor necrosis factor (TNF, 10 ng/ml) and cyclohexamide
(10 
 
m
 
g/ml). Cell viability was determined by trypan blue exclusion. The
supernatant was collected and cell death ELISA was performed as de-
scribed previously (Wang et al., 1999a,b).
For annexin V staining, 2 
 
3
 
 10
 
4
 
 cells were plated on a microscope cover-
slip in 24-well plates the day before stimulation. 16 h after stimulation, cells
were gently washed once with 1
 
3
 
 binding buffer, and stained with annexin
V conjugated with enhanced green fluorescent protein (EGFP) solution (1:
40; CLONTECH Laboratories, Inc.) and propidium iodide (PI, 50 mg/ml,
Sigma-Aldrich) for 15 min at room temperature in the dark. After staining,
cells were washed twice with 1
 
3
 
 binding buffer and fixed in 2% formalde-
hyde in PBS, pH 7.4, for 20 min. The coverslips were inverted on a drop of
Vectashield mounting media (Fisher Scientific) on slides, examined, and
photographed under a fluorescence microscope using a filter set for FITC.
For the LacZ survival assay, cells were cotransfected with pcDNA3-
LacZ vector and either pcDNA3-Flag-DN-Tcf4 or empty vector with Su- 
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perfect. 24 h after transfection, cells were treated with VCR or VBL (0.5
 
m
 
g/ml) for an additional 24 h. The cells were then washed with PBS and
fixed with 0.5% gluteraldehyde for 30 min. The cells were stained with
5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
D
 
-galactopyranoside (X-gal) (GIBCO BRL)
for 6 h and blue cells were counted by phase–contrast microscopy. In
some experiments, instead of the cotransfection of pcDNA3-LacZ vector,
cells were transfected with pCMV-EGFP vector. The GFP-expressing
cells were directly examined under a fluorescent microscope. Cell treat-
ments were performed as described above.
 
Western Blot Analysis
 
2 
 
3 
 
10
 
6 
 
cells were plated in a 100-mm plate the day before stimulation. Cells
were treated with VCR or VBL at the concentration of 0.5 
 
m
 
g/ml for the in-
dicated times. The detached and attached cells were collected. Whole cell
extracts were prepared with radioimmune precipitation assay buffer con-
taining 1% NP-40, 5% sodium deoxycholate, 1 mM PMSF, 100 mM sodium
orthovanadate, and 1:100 protease inhibitors cocktail (Sigma-Aldrich). The
proteins were resolved in a 10% SDS-PAGE and transferred to PVDF
membrane with a semi-dry transferer apparatus (Bio-Rad Laboratories).
The membrane was probed with polyclonal antibodies against phospho-
specific c-Jun, Akt, or I
 
k
 
B
 
a
 
 protein (Cell Signaling Technology, Inc.) and
visualized using an enhanced chemiluminescence reagent (Amersham
Pharmacia Biotech), according to the manufacturer’s recommendation. For
detecting the mitochondrial release of cytochrome c, cytosolic extracts were
prepared and examined as described previously (Wang et al., 1999a).
 
In Vitro Caspase-3 and Caspase-9 Activity Assay
 
Cells were treated as described above for Western blot. The detached and
attached cells were collected, washed with PBS, and lysed in 200 
 
m
 
l ice
cold hypotonic lysis buffer provided by the manufacturers (R&D Systems;
CLONTECH Laboratories, Inc.; Promega). The cell extracts were centri-
fuged and supernatants were collected. 200–300 
 
m
 
g of protein extracts
were incubated in reaction buffer containing LEHD-pNA (colorimetric
 
caspase-9 substrate; R&D Systems) or Ac-Asp-Glu-Val-Asp (DEVD)-
pNA (colormetric caspase-3 substrate; CLONTECH Laboratories, Inc.;
Promega) at 37
 
8
 
C for 2–3 h. The samples were analyzed with a plate
reader by measuring the OD at 405 nm.
 
b
 
-Catenin/Tcf Luciferase Assay
 
The pTopflash and pFopflash constructs contain a luciferase reporter un-
der control of consensus Tcf-binding sites and mutated Tcf-binding sites,
respectively (Kolligs et al., 1999). Cells were cotransfected with pTopflash
or pFopflash luciferase reporters and the related expression vectors using
Superfect. pRL-TK 
 
Renilla
 
 luciferase reporter was cotransfected in each
case to normalize for transfection efficiency. Luciferase assays were per-
formed using a dual luciferase system (Promega).
 
Results
 
Wnt-1 Signaling Inhibits Apoptosis
 
To study the molecular mechanisms by which Wnt-1 regu-
lates cell growth and transformation, we previously estab-
lished Rat-1 cell lines stably expressing Wnt-1 gene
(Rat-1/Wnt-1) (Young et al., 1998). This system was used
because the Wnt-1 protein has proven difficult to isolate
or express in soluble or biologically active form, and, in
fact, most studies have ectopically expressed the Wnt-1
gene to study its downstream signaling events (Miller et
al., 1999). In this system, Rat-1/Wnt-1 cells adopt an elon-
gated and refractile appearance and proliferate in serum-
independent conditions. Activation of the Wnt-1 signal
leads to a constitutive upregulation of cytosolic 
 
b
 
-catenin,
Figure 1. Wnt-1 signaling inhibits apoptosis. (A) Wnt-1 sig-
naling inhibits DNA fragmentation induced by VCR or VBL.
Rat-1 cells expressing Wnt-1 (Rat-1/Wnt-1) or control Rat-1
cells expressing b-gal (Rat-1/b-gal) were treated with VCR or
VBL (0.5 mg/ml) for 24 h. 20 ml of cell supernatant from each
cell group were incubated with anti-histone and -DNA anti-
body at room temperature for 2 h. The reaction was measured
with a microplate reader at 405 nm. (B) Wnt-1 signaling inhib-
its cell killing. Cell viability was determined by trypan blue ex-
clusion. The assays were performed in triplicate, and the re-
sults represent the mean value from three independent
experiments. (C) Wnt-1 signaling partially inhibits TNF-medi-
ated killing. Rat-1/Wnt-1 cells and Rat-1/b-gal cells were
treated with TNF (10 ng/ml) plus cyclohexamide (10 mg/ml)
for 24 h. Cell viability was determined by trypan blue exclu-
sion. The assays were performed in triplicate, and the results
are represented as one of three independent experiments. (D)
Annexin V staining of apoptotic cells after VCR or VBL
treatment. Rat-1/Wnt-1 cells or Rat-1/b-gal cells were un-
treated or treated with VCR or VBL (0.5 mg/ml) for 14–16 h.
Cells were stained with EGFP-annexin (1:40) and PI. The
cells were examined by fluorescence microscopy. 
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whereas membrane-associated 
 
b
 
-catenin remains unaf-
fected. Consequently, there is a constitutive activation of
 
b
 
-catenin/Tcf transcription in Rat-1/Wnt-1 cells, but not in
control cells Rat-1/
 
b
 
-gal (Young et al., 1998). Therefore,
this well-characterized cell culture model system was used
to explore whether Wnt-1 signaling regulates apoptosis.
VCR and VBL act by inhibiting microtubule function,
and they are widely used in cancer chemotherapy (Stone
and Chambers, 2000). These compounds were used indi-
vidually to treat Rat-1/Wnt-1 and Rat-1/
 
b
 
-gal cells. To
compare cell death, DNA fragmentation and histone re-
lease from cell culture supernatant were measured with
cell death ELISA. As shown in Fig. 1 A, significantly
greater DNA fragmentation (over threefold) occurred in
Rat-1/
 
b
 
-gal cells than in Rat-1/Wnt-1 cells after VCR or
VBL treatment for 24 h. Trypan blue exclusion analysis
found that treatment with VCR or VBL caused 40–50%
cell death of Rat-1/
 
b
 
-gal cells, but 
 
z
 
20% of Rat-1/Wnt-1
cells (Fig. 1 B). Wnt-1–mediated protection against VCR
or VBL killing was sustained for 48 h (data not shown).
Note that because many dead cells were rapidly lysed, the
percent of cell death in Rat-1/
 
b
 
-gal cells was underscored.
Wnt-1–mediated cell survival was not only specific to che-
motherapeutic agents, since Rat-1/Wnt-1 cells were also
found to be resistant to apoptosis by TNF (Fig. 1 C) and
serum deprivation (data not shown).
To determine whether Wnt-1–mediated survival was
due to the modification of apoptosis, the cells were also
stained with EGFP-conjugate annexin V in conjunction
with PI after VCR or VBL treatment for 14 to 16 h.
Changes in the plasma membrane of the cell surface are
one of the earliest features of cells undergoing apopto-
sis. After initiating apoptosis, phosphatidylserine (PS) is
translocated from the inner face of the plasma membrane
to the cell surface (Salvesen and Dixit, 1997; Cryns and
Yuan, 1998; Green and Reed, 1998). Because annexin V
has a high affinity for PS and can bind to cells with ex-
posed PS, it has been used to detect the early stage of ap-
optosis (Wang et al., 1998, 1999a). As shown in Fig. 1 D,
compared with numerous annexin V positive–stained cells
in the Rat-1/
 
b
 
-gal group, only limited staining was de-
tected in the Rat-1/Wnt-1 group after VCR or VBL stimu-
lation. Annexin V–positive cells failed to take up PI (data
not shown), indicating cell death via apoptosis, but not ne-
crosis. Together, these results demonstrated that Wnt-1
signaling provided protection against chemotherapeutic
agent–induced apoptosis.
 
Wnt-1 Signaling Blocks the Mitochondrial Release of 
Cytochrome C and the Subsequent
Caspase-9 Activation
 
Next, we examined the molecular mechanism by which
Wnt-1 signal transduction inhibits VCR- or VBL-medi-
ated apoptosis. To initiate apoptosis, stress inducers such
as chemotherapeutic agents damage mitochondria by un-
known mechanisms, leading to the release of cytochrome c
from mitochondria to the cytosol (Soengas et al., 1999;
Wang et al., 1999a; Tournier et al., 2000). Cytochrome c
interacts with Apaf-1, caspase-9, and ATP leading to the
formation of an oligomeric multiprotein complex, the ap-
optosome. Oligomerization of Apaf-1 leads to activation
of caspase-9 (Li et al., 1996; Zou et al., 1997). Biochemical
studies have demonstrated that the cytochrome c–medi-
ated Apaf-1 apoptosome plays an essential role in the
cancer therapy–mediated apoptosis (Kuida et al., 1998;
Yoshida et al., 1998; Soengas et al., 1999). Bcl-2 family
proteins have been found to inhibit chemotherapeutic
agent–mediated apoptosis by preventing cytochrome c re-
lease from mitochondria (Kluck et al., 1997; Yang et al.,
1997). To determine whether Wnt-1 inhibits VCR- or
VBL-induced cytochrome c release, cytosolic fractions
were extracted as described previously (Wang et al., 1998,
1999a). As shown in Fig. 2 A, the release of cytochrome c
from mitochondria was suppressed in the Rat-1/Wnt-1
cells, but not in the Rat-1/
 
b
 
-gal cells. Since cytochrome c is
required for the activation of procaspase-9, we measured
caspase-9 activity using LEHD as a substrate. As shown in
Fig. 2 B, caspase-9 activity was significantly inhibited in
the Rat-1/Wnt-1 cells, after the addition of either VCR or
VBL, compared with Rat-1/
 
b
 
-gal cells. Since activated
caspase-9 amplifies the apoptotic program by cleaving
and activating downstream executive caspases, such as
caspase-3 (Cryns and Yuan, 1998), we also determined
whether caspase-3 activity was inhibited in Rat-1/Wnt-1
cells. Consistent with above results, significantly lower
DEVDase activity was present in the Rat-1/Wnt-1 cells
Figure 2. Wnt-1 signaling inhibits VCR- and VBL-mediated cy-
tochrome c release and subsequent caspase-9 activation. (A)
Wnt-1 signaling blocked the cytochrome c release. Both Rat-1/
Wnt-1 and Rat-1/b-gal cells were treated with VCR or VBL for
the indicated times. Cells were fractionated, as described previ-
ously, and cytosolic proteins were resolved on a 15% SDS-PAGE
and transferred to PVDF membrane with a semi-dry transfer
unit. The membrane was probed with a monoclonal antibody
against cytochrome c, and the signal was visualized with en-
hanced chemiluminescence. For internal controls, the blots were
stripped and reprobed with monoclonal antibody against a-tubu-
lin (1:2,000). (B) Wnt-1 signaling inhibits caspase-9 activation.
Cells were treated with VCR or VBL (0.5 mg/ml) for 16 h. The
detached and attached cells were harvested and whole cell ex-
tracts were prepared. 200-mg aliquots of protein extracts were in-
cubated with caspase-9 substrate LEHD-pNA (100 mM) for 2–3 h
at 378C. The reaction was measured with a plate reader at 405
nm. The results represent the average values from the two inde-
pendent experiments. (C) Wnt-1 signaling inhibits caspase-3 acti-
vation. Whole cell protein extracts were prepared as described in
the legend to B. 200-mg aliquots of protein extracts were incu-
bated with DEVD-pNA substrate for 3 h at 378C, and the reac-
tion was recorded at 405 nm. 
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compared with in the Rat-1/
 
b
 
-gal cells after VCR or VBL
stimulation (Fig. 2 C). These results demonstrated that
Wnt-1 suppressed apoptosis by preventing the release of
cytochrome c from mitochondria and the subsequent acti-
vation of Apaf-1–caspase-9 apoptosome.
 
Pro-Apoptotic JNK (c-Jun NH
 
2
 
-terminal Kinase) Stress 
Signaling Pathway and Anti-Apoptotic Akt Signaling 
Pathways Are Not Involved in the
Wnt-1–mediated Survival
 
JNK is a member of the stress-activated group of mitogen-
activated protein kinases that are activated by multiple
stress inducers. Growing evidence indicates that the activa-
tion of the JNK pathway plays a critical role in chemother-
apeutic agent–induced apoptosis (Xia et al., 1995; Tournier
et al., 2000). As microtubule inhibitors, both VCR and
VBL have been found to be potent activators of the JNK
pathway (Stone and Chambers, 2000). Interestingly, a
downstream mediator of Wnt-1 signaling, dishevelled, has
been shown to activate the JNK pathway (Boutro et al.,
1998; Li et al., 1999). Thus, we examined whether Wnt-1
signaling modulates the JNK pathway. As shown Fig. 3 A,
the kinetics of JNK activation, induced by both VCR and
VBL, were almost identical in Rat-1/Wnt-1 and Rat-1/
 
b
 
-
gal cells. Although JNK activation was involved in the
VCR- or VBL-mediated apoptosis, our results indicated
that Wnt-1–mediated prosurvival was not dependent on
the modification of JNK pathway in this system.
Akt, also referred to as PKB (protein kinase B), is a
serine/threonine protein kinase that has been shown to in-
hibit apoptosis in response to multiple growth factors and
mitogens (Datta et al., 2000; Madrid et al., 2000). Thus, we
also compared whether there were any differences in Akt
activity after VCR or VBL stimulation in both cell lines.
As shown in Fig. 3 B, Rat-1/Wnt-1 and Rat-1/
 
b-gal cells
displayed similar levels of basal phorsphorylation activity
that decreased with similar kinetics after VCR or VBL
treatment. The results also were consistent with a previous
report that stress stimuli can inhibit Akt activity (Zundel
and Giaccia, 1998). Finally, we also examined whether
Wnt-1 signaling regulates another anti-apoptotic media-
tor, namely, the transcription factor NF-kB (nuclear factor
kB), which has been found to play an important role in
inhibition of TNF- or chemotherapy-induced apoptosis
(Wang et al., 1996, 1998, 1999a,b; Madrid et al., 2000).
Classic NF-kB is described as the p50–p65 heterodimer
that is typically found sequestered in the cytoplasm by the
IkB group of inhibitory proteins. The nuclear transloca-
tion of NF-kB occurs rapidly after the IkB kinase (IKK)–
mediated phosphorylation and subsequent degradation of
IkB. Thus, using a polyclonal antibody against phospho-
specific IkBa, we assessed IKK activity in Rat-1/Wnt-1
cells and Rat-1/b-gal cells after VCR or VBL stimulation.
As shown in Fig. 3 C, the kinetics of IKK activation was
similar in both cell lines. Additionally, use of an NF-kB–
responsive promoter construct in transfections of both cell
lines showed no difference in NF-kB transcriptional activ-
ity after VCR or VBL treatment (Chen, S., and C.-Y.
Wang, unpublished observation). Together, these data ar-
gue that the anti-apoptotic function of Wnt-1 is not medi-
ated through its modulation of either JNK, Akt, or NF-kB
activity.
Wnt-1–mediated Cell Survival Is Dependent on the 
Activation of b-Catenin/Tcf–mediated Transcription
Rat-1/Wnt-1 cells were previously shown to induce the
constitutive activation of b-catenin/Tcf–mediated tran-
scription by substantially increasing the level of cytosolic
b-catenin (Young et al., 1998). Thus, we determined
whether Wnt-1–mediated cell survival was dependent on
b-catenin/Tcf transcription. Previous studies have demon-
Figure 3. Wnt-1 signaling does not modulate the activation of
JNK, Akt kinase, and IKK. Both Rat-1/Wnt-1 and Rat-1/b-gal
cells were treated with VCR or VBL (0.5 mg/ml) for the indicated
times, and whole cell extracts were subsequently prepared. 50 mg
of proteins were resolved on a 10% SDS-PAGE gel. The blots
were incubated with polyclonal antibodies against phospho-spe-
cific c-Jun (A), Akt (B), or IkBa protein (C) at 48C overnight, re-
spectively. For internal controls, the blots were stripped and re-
probed with monoclonal antibody against a-tubulin (1:2,000) or
polyclonal antibody against Akt (1:1,000).
Figure 4. Inhibition of constitutive ac-
tivation of b-catenin/Tcf transcription
by DN-Tcf. (A) Establishment of sta-
ble Rat-1/Wnt-1 transfectants express-
ing the dominant-negative mutant of
Tcf-4. Rat-1/Wnt-1 cells were cotrans-
fected with pcDNA3-Flag-DN-Tcf vec-
tor or control empty vector and pBabe
vector containing puromycin selectable
marker and selected with puromycin (1
mg/ml) for 2 wk. About 80 resistant
clones were screened with monoclonal
antibody against flag epitope. The five
positive clones were acquired and
pooled together as Rat-1/Wnt-1/DN-
Tcf cells. Lane 1 represents the stable
control clones expressing puromycin-resistant marker (Rat-1/
Wnt-1/P); lane 2 and 3 represent the stable Rat-1/Wnt-1/DN-Tcf
expressing flag-DN-Tcf. For internal controls, the blots were
stripped and reprobed with monoclonal antibody against a-tubu-
lin (1:2,000). (B) Inhibition of b-catenin/Tcf transcription by DN-
Tcf. Rat-1/Wnt-1/DN-Tcf cells and Rat-1/Wnt-1/P cells were
transfected with either pTopflash or pFopflash luciferase re-
porter plasmid. The pRL-TK Renilla luciferase reporter was
cotransfected to normalize for transfection efficiency. Luciferase
activity was measured 1 d after transfection. The fold activation
was determined by comparing with pTopflash activity with pFop-
flash luciferase activity. Transcriptional activation values repre-
sent triplicate samples that were counted and averaged.The Journal of Cell Biology, Volume 152, 2001 92
strated that the Tcf NH2 terminus is required for binding
to b-catenin and that Tcf mutant proteins lacking NH2-ter-
minal sequences retain DNA-binding activity, but function
in a dominant-negative fashion (Behrens et al., 1996; Ko-
rinek et al., 1997; Kolligs et al., 1999; Prieve and Water-
man, 1999). To inhibit b-catenin/Tcf–mediated transcrip-
tion, Rat-1/Wnt-1 cells were stably transfected with a
dominant-negative mutant of the Tcf-4 construct or an
empty vector as a control. Five positive clones expressing
DN-Tcf were identified and pooled as Rat-1/Wnt-1/DN-
Tcf cells according to the level of protein expression (Fig.
4 A, lanes 2 and 3). The puromycin-resistant clones, which
expressed empty vector, were pooled and designed as con-
trol cells Rat-1/Wnt-1/P cells (Fig. 4 A, lane 1). Interest-
ingly, Rat-1/Wnt-1/DN-Tcf cells exhibited morphologies
and growth characteristics similar to those of Rat-1/b-gal
cells, indicating DN-Tcf functionally blocked Wnt-1 signal
transduction (data not shown). To confirm that DN-Tcf
inhibited Wnt-1–mediated constitutive activation of b-cate-
nin/Tcf transcription, Rat-1/Wnt-1/DN-Tcf cells and Rat-
1/b-gal/P cells were transfected with pTopflash or pFop-
flash luciferase reporter. The pTopflash and pFopflash
constructs contain the luciferase reporter either under the
control of consensus Tcf-binding sites or mutated Tcf-
binding sites, respectively (Korinek et al., 1997; He et al.,
1998; Kolligs et al., 2000; Xu et al., 2000). As shown in Fig.
4 B, the b-catenin/Tcf transcription activity was also sup-
pressed in Rat-1/Wnt-1/DN-Tcf cells. We then determined
whether inhibition of b-catenin/Tcf–mediated transcrip-
tion rendered cells sensitive to VCR- or VBL-mediated
killing. As shown in Fig. 5 A, nearly 50% of Rat-1/Wnt-1/
DN-Tcf cells, compared with only 20% of Rat-1/Wnt-1/P
cells, were killed after VCR and VBL stimulation. In addi-
tion, the increase in both annexin V and DNA fragmenta-
tion indicated that restoration of cell death by the expres-
sion of DN-Tcf was dependent on the apoptotic program
(Fig. 5, B and C). Taken together, these results indicated
that Wnt-1–mediated anti-apoptosis was dependent on the
b-catenin/Tcf–mediated transcription.
Because Wnt signaling promotes the accumulation of
b-catenin, we also determined whether the overexpression
of stable b-catenin containing a missense mutation of ty-
rosine for serine at codon 33 (S33Y) directly inhibited
VCR- or VBL-mediated apoptosis by the transient trans-
fection. As shown in Fig. 5 D, the overexpresion of b-cate-
nin (S33Y), but not control vector, in Rat-1/b-gal cells sig-
nificantly inhibited VCR- or VBL-mediated killing and
coexpression of DN-Tcf blocked b-catenin–mediated sur-
vival. Interestingly, though coexpression of DN-Tcf also
blocked Wnt-mediated survival, overexpression of Wnt-1
by the transient transfection more potently inhibited
VCR- or VBL-mediated killing than that of b-catenin, in-
dicating that Wnt-1 may activate other signaling pathways
or molecules to enhance b-catenin/Tcf–mediated anti-apop-
totic function (Fig. 5 D).
If Wnt-1–mediated b-catenin/Tcf transcription sup-
pressed the mitochondrial release of cytochrome c in-
duced by VCR or VBL, the inhibition of Tcf transcription
Figure 5. Wnt-1–mediated
anti-apoptosis is dependent on
the activation of b-catenin/Tcf
transcription. (A) Inhibition
of Tcf transcription renders
cells sensitive to VCR- or
VBL-mediated killing. Both
Rat-1/Wnt-1/DN-Tcf cells and
Rat-1/Wnt-1/P cells were
treated with VCR or VBL (0.5
mg/ml) for 24 h. The detached
and attached cells were har-
vested and cell viability was
determined with trypan blue
exclusion. DN-Tcf represents
Rat-1/Wnt-1/DN-Tcf cells. (B)
Annexin V staining of apop-
totic cells after VCR or VBL
treatment. Rat-1/Wnt-1/DN-
Tcf cells or Rat-1/b-gal/P cells
were untreated or treated with
VCR or VBL (0.5 mg/ml) for
14–16 h. Cells were stained
with EGFP-annexin (1:40)
and PI. The cells were exam-
ined by fluorescence micros-
copy. DN-Tcf represents Rat-
1/Wnt-1/DN-Tcf cells. (C) Cell supernatants from A were measured with a cell death ELISA kit, as described
in the legend to Fig. 1 A. The assays were performed in triplicate. The results represent the average values
from three independent experiments. DN-Tcf represents Rat-1/Wnt-1/DN-Tcf cells. (D) Rat-1/b-gal cells were
cotransfected with pCMV-EGFP vector and either pcDNA3–b-catenin (S33Y), pcDNA3–b-catenin (S33Y)
plus pcDNA3–DN-Tcf, pCMV-HA-Wnt, pCMV-HA-Wnt plus pcDNA3–DN-Tcf, or control vector. 24 h af-
ter transfection, cells were treated with VCR or VBL for an additional 24 h. The GFP-expressing cells were ex-
amined by fluorescence microscopy. The assays were performed in duplicate. The results represent the aver-
age value of three independent experiments. b-cat, b-catenin (S33Y).Chen et al. Inhibition of Apoptosis by Wnt Signaling 93
should restore the apoptotic potential of these chemother-
apeutic agents. As predicted, both VCR and VBL potently
induced cytochrome c release from mitochondria to the
cytosol in Rat-1/Wnt-1/DN-Tcf cells, but not in Rat-1/
Wnt-1/P cells (Fig. 6 A). Consistent with cytochrome c
function, there was higher activity of caspase-9 and
caspase-3 in Rat-1/Wnt-1/DN-Tcf cells than in Rat-1/Wnt-
1/P cells after VCR or VBL stimulation (Fig. 6, B and C). In
conclusion, these results confirmed that the Wnt-1–medi-
ated  b-catenin/Tcf transcription inhibited apoptosis by
preventing the release of cytochrome c from mitochondria
and the subsequent activation of caspase-9.
Inhibition of b-Catenin/Tcf–mediated Transcription 
Potentiates Apoptosis in Human Colorectal
Cancer Cells
Abnormal activation of b-catenin/Tcf–mediated transcrip-
tion has been widely found in human cancers, including
colorectal carcinomas. The well-characterized human col-
orectal cancer cell line SW480 has been found to contain a
constitutively high level of b-catenin/Tcf–mediated tran-
scriptional activity due to the inactivation of the APC tu-
mor suppressor gene (Munemitsu et al., 1995; Korinek et
al., 1997; He et al., 1998). The expression of DN-Tcf con-
struct inhibited the constitutive activation of b-catenin/Tcf
transcription in SW480 cells (Fig. 7 A). Using this cell line,
we examined whether inhibition of endogenous b-catenin/
Tcf transcription potentiated VCR- or VBL-mediated ap-
optosis by the transient transfection assay. As shown in
Fig. 7 B, though the expression of DN-Tcf alone didn’t af-
fect cell survival, VCR- and VBL-mediated killing was sig-
nificantly enhanced by the expression of DN-Tcf vector,
but not empty vector, as determining the LacZ-positive
cells (blue cells). Morin et al. (1996) had reported that the
expression of APC in a human colorectal cell line HT-29
induced apoptosis by unknown mechanisms, using an in-
ducible expression system. Subsequent studies by several
groups demonstrated that induction of the expression of
APC in that cell line reduced the level of b-catenin and in-
hibited the b-catenin/Tcf–mediated transcription (Ko-
rinek et al., 1997; Kolligs et al., 2000). Thus, we also used
this cell line to examine whether the inhibition of b-cate-
nin/Tcf modulated VCR- or VBL-mediated killing. Inter-
estingly, in the absence of VCR or VBL stimulation,
z60% of cells were killed after the transfection of DN-Tcf
compared with that of control vector (Fig. 7 C). The dead
cells were rounded up and detached from plates with ap-
optotic characteristics, including condensed chromatin and
fragmented nuclei (data not shown). In the presence of
VCR or VBL stimulation, only 20% of cells transfected
with DN-Tcf compared with 50% of cells transfected with
control vector were alive (Fig. 7 C). Taken together, our
findings demonstrated that the inhibition of endogenous
b-catenin/Tcf–mediated transcription in human colorectal
cells potentiated VCR- or VBL-mediated apoptosis and/
or induced spontaneous apoptosis.
Figure 6. Inhibition of Tcf transcription renders cell sensitive to
VCR- or VBL-mediated cytochrome c release. (A) Both Rat-1/
Wnt-1/P and DN-Tcf cells were treated with VCR or VBL (0.5 mg/
ml) for the indicated times. Cytosolic proteins were detected with
a monoclonal antibody against cytochrome c, as described in the
legend to Fig. 3 A. (B and C) Inhibition of Tcf transcription ren-
ders cells sensitive to VCR- or VBL-mediated caspase activation.
Cells were treated with VCR or VBL (0.5 mg/ml) for 16 h. The de-
tached and attached cells were harvested and whole cell proteins
were extracted according to the manufacturer’s instruction. 200 mg
of proteins were incubated with LEHD-pNA substrate and 200 mg
proteins were incubated with DEVD-pNA substrate. The results
represent the average value from two independent experiments.
DN-Tcf represents Rat-1/Wnt-1/DN-Tcf.
Figure 7. Inhibition of constitutive
activation of Tcf transcription ren-
der cell sensitive to VCR- or VBL-
mediated apoptosis. (A) The ex-
pression of DN-Tcf inhibits the
constitutive activation of b-catenin/
Tcf transcription. SW480 cells were
cotransfected with pTopflash or
pFopflash luciferase report plas-
mid and pcDNA3-flag-DN-Tcf,
pcDNA-APC vector, or control
empty vector with Superfect. PRL-
TK Renilla luciferase reporter was
cotransfected in each case to nor-
malize for transfection efficiency.
24 h after transfection, luciferase
assays were performed using a dual
luciferase system. The fold activa-
tion was determined by comparing
pTopflash activity with pFopflash
luciferase activity. Each group of
assays was performed in triplicate
and results represent from one of
three independent experiments. (B)
Inhibition of constitutive b-catenin/Tcf transcription renders cells
sensitive to VCR- or VBL-mediated killing. SW480 cells were
cotransfected with pcDNA3-LacZ and pcDNA3-flag-DN-Tcf
vector or control vector for 24 h. After transfection, cells were
treated with VCR or VBL (0.5 mg/ml) for an additional 24 h.
Cells were fixed with 0.5% gluteraldehyde and incubated with
5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-gal) (0.5
mg/ml) for 6 h. The blue-positive cells were counted from three
fields in each well. The assays were performed in triplicate. The
results represent the average value of two independent experi-
ments. (C) Inhibition of b-catenin/Tcf transcription induces
spontaneous apoptosis in HT29 cells. HT29 cells were cotrans-
fected with pCMV-EGFP and either pcDAN3-DN-Tcf or control
vector. Cell treatments were performed as described in the leg-
end to B. The GFP-expressing cells were counted by fluorescence
microscopy. The assays were performed in duplicate. The results
represent the average value of three independent experiments.The Journal of Cell Biology, Volume 152, 2001 94
Discussion
Wnt proteins represent a growing family of secreted sig-
naling molecules that are expressed in diverse tissues and
have been shown to regulate cell proliferation, growth,
and differentiation (Cadigan and Nusse, 1997; Miller et al.,
1999; Peifer and Polakis, 2000). Importantly, the deregula-
tion of the Wnt-1 signaling pathway has been linked with
tumorigenesis, presumably by promoting cell growth and
proliferation. Here, we demonstrated that Wnt-1, a funda-
mental member of the Wnt family proteins, potently inhib-
ited chemotherapy-mediated apoptosis. Given that many
oncogenes transform cells by providing cell survival func-
tion, our results also indicate that Wnt-1 may transform
cells via an anti-apoptotic mechanism, in addition to pro-
moting cell growth and proliferation. Interestingly, c-myc,
a potent oncogene that promotes cell cycle progression, is
a  b-catenin/Tcf transcriptional target (He et al., 1998).
However, studies have demonstrated that c-myc–mediated
transformation requires other survival signals to prevent
apoptosis (Miller et al., 1999; Soengas et al., 1999). Our re-
sults indicate that Wnt-1–mediated b-catenin/Tcf tran-
scription is also an important survival pathway. It not only
plays a role in the promotion of cell proliferation and cell
cycle progression, but also may provide an important sur-
vival function to facilitate cell transformation.
The downstream mediators of Wnt-1 signal pathway in-
clude dishevelled, b-catenin, APC, GSK-3b, and axin
(Miller et al., 1999; Polakis, 2000; Salic et al., 2000). Over-
expression of APC has been shown to induce apoptosis in
the human colorectal cancer cell line HT-29 by unknown
mechanisms (Morin et al., 1996). Using this cell line, we
found that the inhibition of endogenous b-catenin/Tcf–
mediated transcription also triggered cell suicide program.
Given the fact that overexpression of APC has been
shown to destabilize b-catenin and inhibit b-catenin/Tcf–
mediated transcription (Korinek et al., 1997; Kolligs et al.,
2000), our findings suggest that APC-induced apoptosis
was through the inhibition of b-catenin/Tcf–mediated
transcription. Wnt signaling activates dishevelled to inhibit
GSK-3b activity, resulting in the stabilization of b-catenin
and the activation of b-catenin/Tcf–mediated transcrip-
tion. Thus, b-catenin stabilization, as well as the formation
of a complex with Tcf transcription factors, is likely to play
a critical role in Wnt-mediated anti-apoptosis. Indeed,
overexpression of b-catenin can overcome anoikis and
promote cell cycle progression (Orford et al., 1999). Con-
sistent with that study, our results demonstrated that over-
expression of b-catenin also inhibited chemotherapeutic
drug–mediated apoptosis, though it was relatively weaker
than that of Wnt-1. However, the dominant-negative mu-
tant of Tcf rendered cell sensitive to apoptotic stimuli,
which indicated that Wnt-1–mediated anti-apoptosis was
dependent on b-catenin/Tcf–mediated transcription. In
contrast, Hetman et al. (2000) found that the expression of
b-catenin could not protect cortical neurons from apopto-
sis induced by trophic withdrawal. This difference may be
due to both a cell type and apoptotic stimuli. Additionally,
in that cell model system, GSK-3b activation might be a
dominant pro-apoptotic signal that could not be inhibited
by b-catenin. During the preparation of this manuscript, it
is reported that Wnt signaling was involved in B-lympho-
cyte survival and proliferation (Reya et al., 2000), and that
Wnt-1 promoted cell survival in the absence of serum
(Bournat et al., 2000). Our results, presented here, signifi-
cantly extend these findings and provide the first demon-
stration that Wnt-1 signaling is associated with chemore-
sistance. Furthermore, we have elucidated the molecular
mechanism by which Wnt-1 activation inhibits apoptosis.
Our results demonstrated that Wnt-1–mediated b-catenin/
Tcf transcription blocked chemotherapy-mediated cyto-
chrome c release and subsequent caspase-9 activation.
However, our results cannot rule out the possibility that
Wnt-1–mediated b-catenin/Tcf transcription also plays a
role in other steps of caspase activation cascade. Recently,
Steinhusen et al. (2000) have demonstrated that b-catenin
is cleaved by caspase-3 during staurosporine-induced ap-
optosis and that cleaved b-catenin reduced its transactiva-
tion potential. Although we could not find that b-catenin
was cleaved in our cell model system, it suggests that some
apoptotic stimuli may antigonize Wnt-mediated survival
signaling by cleaving b-catenin.
Overexperssion of dishevelled, which is known to posi-
tively mediate b-catenin stabilization in the Wnt-1 signaling
pathway, has also been shown to induce apoptosis (Strovel
and Sussman, 1999). Although apparently inconsistent with
our current findings, genetic and biochemical studies have
demonstrated that dishevelled also functions to activate the
JNK pathway, in addition to transducing Wnt signals for
the stabilization of b-catenin. The activation of JNK has
been found to play a critical role in initiating apoptosis (Xia
et al., 1995; Tournier et al., 2000). Thus, overexpression of
dishevelled may abnormally activate the JNK pro-apop-
totic signaling that can suppress the b-catenin/Tcf–medi-
ated survival function, leading cells down the apoptotic
pathway. Finally, in our model system, JNK was not acti-
vated by Wnt-1 signaling, which indicates that dishevelled
primarily mediated the Wnt-1 pro-survival functions under
physiological conditions. Interestingly, GSK-3b has also
been found to have both pro- and anti-apoptotic functions
(Pap and Cooper, 1998; Hetman et al., 2000; Hoeflich et al.,
2000). Inhibition of GSK-3b by phosphatidyinositol-3
kinase  (PI3K)/Akt promotes cell survival and activation of
GSK-3b by trophic withdrawal and induces apoptosis (Pap
and Cooper, 1998; Hetman et al., 2000). Our results also in-
dicate that GSK-3b is a pro-apoptotic molecule. Paradoxi-
cally, GSK-3b activation has been found to play an anti-
apoptotic role in TNF-mediated apoptosis by activation of
NF-kB. However, how GSK-3b stimulates NF-kB tran-
scription is unknown. According to studies by Ding et al.
(2000) and others (Yost et al., 1996; Yuan et al., 1999; Het-
man et al., 2000), it is likely that GSK-3b may exist in sev-
eral signaling complexes. One is in the APC–axin–conduc-
tin complex that is in specific response to Wnt signaling;
one is regulated by PI3K/Akt, but not Wnt signaling; and
one is responsible for TNF-induced NF-kB activation. The
inhibition of GSK-3b in the APC–axin–conductin complex
by Wnt or in the PI3K/Akt-responsive complex by growth
factors may lead to cell survival, whereas the inhibition of a
fraction of GSK-3b, leading to inactivation of NF-kB, may
render cells sensitive to TNF killing.
Several important genes, including c-myc and cyclin D1,
have been found to be regulated by Wnt (He et al., 1998;
Shtutman et al., 1999; Tetsu and McCormick, 1999). Cur-
rently, it is unknown whether Wnt-1 signaling regulates
the expression of anti-apoptotic genes. Since Bcl-2 familyChen et al. Inhibition of Apoptosis by Wnt Signaling 95
proteins have been found to play roles in the mitochondria
and inhibit chemotherapy-mediated apoptosis (Chao and
Korsmeyer, 1998; Green and Reed, 1998), we have applied
gene array analysis to examine whether Wnt-1–mediated
b-catenin/Tcf transcription regulates the expression of
Bcl-2 family proteins, including Bcl-2, Bcl-xL, Bax, Bad,
and Bik. No differences have been found in the expression
of these genes between Rat-1/Wnt-1 cells and Rat-1/b-gal
cells, suggesting that Bcl-2 family members are not direct
transcription targets of Wnt-1 signaling. However, we can-
not rule out the possibility that Wnt-1 signaling or Wnt-
1–mediated b-catenin/Tcf transcription may posttransla-
tionally modify these proteins. We also performed Western
blot analysis to examine another group of anti-apoptotic
molecules, namely inhibitors of apoptosis (IAP), including
c-IAP1, c-IAP2, and X-linked IAP (Crawford et al., 1999a;
Vaux, 1999; Verhagen et al., 2000; Chen, S., and C.-Y.
Wang, unpublished observation). Again, no differences
were found between Rat-1/Wnt-1 and Rat-1/b-gal cells.
Reya et al. (2000) reported that the fas gene is negatively
regulated by Lef-1 transcription. However, in our model
system, Fas was not involved in the VCR- or VBL-medi-
ated apoptosis (data not shown). Thus, these results indi-
cate that Wnt-1–mediated b-catenin/Tcf transcription may
regulate other anti-apoptosis molecules yet to be identi-
fied.
Considering the fact that the constitutive activation of
b-catenin/Tcf transcription has been found in a variety of
human cancers, our results have important implications
for human cancer therapy. The constitutive activation of
b-catenin/Tcf transcription, at least, has a dual function,
though it may have other functions as well. One is to pro-
mote cell cycle progression and cell proliferation, as de-
scribed previously (Miller et al., 1999; Polakis, 2000). An-
other is to provide cell survival function. Therefore, in the
future, the application of a gene therapy approach or the
development of small molecules to inhibit b-catenin/Tcf–
mediated transcription may improve the efficacy of che-
motherapy by enhancing apoptosis in cancer cells.
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